{"id":"https://openalex.org/W4362494043","doi":"https://doi.org/10.1158/1535-7163.22500241","title":"Supplementary Figure 2 from Potential Advantages of CUDC-101, a Multitargeted HDAC, EGFR, and HER2 Inhibitor, in Treating Drug Resistance and Preventing Cancer Cell Migration and Invasion","display_name":"Supplementary Figure 2 from Potential Advantages of CUDC-101, a Multitargeted HDAC, EGFR, and HER2 Inhibitor, in Treating Drug Resistance and Preventing Cancer Cell Migration and Invasion","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362494043","doi":"https://doi.org/10.1158/1535-7163.22500241"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22500241","doi":"https://doi.org/10.1158/1535-7163.22500241","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22500241","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Potential_Advantages_of_CUDC-101_a_Multitargeted_HDAC_EGFR_and_HER2_Inhibitor_in_Treating_Drug_Resistance_and_Preventing_Cancer_Cell_Migration_and_Invasion/22500241/1/files/39959518.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Potential_Advantages_of_CUDC-101_a_Multitargeted_HDAC_EGFR_and_HER2_Inhibitor_in_Treating_Drug_Resistance_and_Preventing_Cancer_Cell_Migration_and_Invasion/22500241/1/files/39959518.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100378537","display_name":"Jing Wang","orcid":"https://orcid.org/0000-0002-5398-0802","observed_orcids":["https://orcid.org/0000-0002-5398-0802","https://orcid.org/0000-0001-5412-9860"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jing Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091117919","display_name":"Natalie W. Pursell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Natalie W. Pursell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110461270","display_name":"Maria Samson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maria Elena S. Samson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065104224","display_name":"Ruzanna Atoyan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ruzanna Atoyan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Anna W. Ma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Anna W. Ma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039372671","display_name":"Abdelkader Selmi","orcid":"https://orcid.org/0000-0001-5760-0507","observed_orcids":["https://orcid.org/0000-0001-5760-0507"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abdelkader Selmi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071635528","display_name":"Wanlu Xu","orcid":"https://orcid.org/0000-0002-8838-9879","observed_orcids":["https://orcid.org/0000-0002-8838-9879"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wanlu Xu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100770695","display_name":"Xiong Cai","orcid":"https://orcid.org/0000-0003-2034-9130","observed_orcids":["https://orcid.org/0000-0003-2034-9130"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiong Cai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079238859","display_name":"Maurizio Voi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maurizio Voi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002455905","display_name":"Pierre Savagner","orcid":"https://orcid.org/0000-0002-8287-2229","observed_orcids":["https://orcid.org/0000-0002-8287-2229"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Pierre Savagner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5018703558","display_name":"Cheng-Jung Lai","orcid":"https://orcid.org/0000-0002-3321-8984","observed_orcids":["https://orcid.org/0000-0002-3321-8984"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cheng-Jung Lai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.6215999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.6215999722480774,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.1964000016450882,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.1388999968767166,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cudc-101","display_name":"CUDC-101","score":1.0},{"id":"https://openalex.org/keywords/erlotinib","display_name":"erlotinib","score":0.902999997138977},{"id":"https://openalex.org/keywords/egfr-inhibitors","display_name":"EGFR inhibitors","score":0.5860000252723694},{"id":"https://openalex.org/keywords/her2","display_name":"HER2","score":0.6340000033378601},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.8889999985694885},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8600000143051147},{"id":"https://openalex.org/keywords/hcc827-cells","display_name":"HCC827 cells","score":0.8299999833106995},{"id":"https://openalex.org/keywords/tumor-cell-migration","display_name":"tumor cell migration","score":0.8289999961853027},{"id":"https://openalex.org/keywords/tumor-invasion","display_name":"tumor invasion","score":0.8759999871253967},{"id":"https://openalex.org/keywords/lung-cancer","display_name":"lung cancer","score":0.4490000009536743}],"concepts":[{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.5291120409965515},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5283905863761902},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.48312637209892273},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.47971051931381226},{"id":"https://openalex.org/C2777506169","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"EGFR inhibitors","level":4,"score":0.4666191637516022},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3645157516002655},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33503973484039307},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.29830071330070496},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15716606378555298},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.1452242136001587},{"id":"https://openalex.org/C89423630","wikidata":"https://www.wikidata.org/wiki/Q7193","display_name":"Microbiology","level":1,"score":0.09135684370994568}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1158/1535-7163.22500241","doi":"https://doi.org/10.1158/1535-7163.22500241","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22500241","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Potential_Advantages_of_CUDC-101_a_Multitargeted_HDAC_EGFR_and_HER2_Inhibitor_in_Treating_Drug_Resistance_and_Preventing_Cancer_Cell_Migration_and_Invasion/22500241/1/files/39959518.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"doi:10.1158/1535-7163.22500241.v1","doi":"https://doi.org/10.1158/1535-7163.22500241.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22500241.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22500241","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Potential_Advantages_of_CUDC-101_a_Multitargeted_HDAC_EGFR_and_HER2_Inhibitor_in_Treating_Drug_Resistance_and_Preventing_Cancer_Cell_Migration_and_Invasion/22500241","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22500241","doi":"https://doi.org/10.1158/1535-7163.22500241","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22500241","pdf_url":"https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Potential_Advantages_of_CUDC-101_a_Multitargeted_HDAC_EGFR_and_HER2_Inhibitor_in_Treating_Drug_Resistance_and_Preventing_Cancer_Cell_Migration_and_Invasion/22500241/1/files/39959518.pdf","source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4362494043.pdf","grobid_xml":"https://content.openalex.org/works/W4362494043.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4362495338","https://openalex.org/W2164868034","https://openalex.org/W2058961982","https://openalex.org/W2314812170","https://openalex.org/W4392684655","https://openalex.org/W2118661220","https://openalex.org/W2322593713","https://openalex.org/W2068473772","https://openalex.org/W4361945450","https://openalex.org/W2135971557"],"abstract_inverted_index":{"PDF":[0],"file":[1],"-":[2],"140K,":[3],"Changes":[4],"in":[5,15],"subcellular":[6],"markers":[7],"induced":[8],"by":[9],"treatment":[10],"with":[11],"CUDC-101":[12],"or":[13],"erlotinib":[14],"parental":[16],"and":[17],"erlotinib-TR":[18],"HCC827":[19],"cells.":[20]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-05T00:00:00"}